Over The Counter Coronavirus Treatment Update

on wednesday, july 28, the fda revised the eua for baricitinib (sold under the brand name olumiant) now authorizing baricitinib alone for the treatment of. Many medications are authorized for emergency use to treat COVID-19, including oral treatments like Paxlovid (nirmatrelvir and ritonavir) and Lagevrio (molnupiravir). In May 2022, the FDA approved Olumiant (baricitinib) to treat certain adults who are hospitalized with COVID-19. It’s the second medication that’s fully approved for COVID-19. The NHS offers treatments to people with coronavirus (COVID-19) who are at the highest risk of becoming seriously ill.

The treatments available are: nirmatrelvir and ritonavir (Paxlovid) sotrovimab (Xevudy) remdesivir (Veklury) molnupiravir (Lagevrio) Nirmatrelvir, ritonavir, remdesivir and molnupiravir are antiviral medicines.